Efficacy and safety of intravenous cyclophosphamide pulse therapy with oral prednisolone in the treatment of interstitial lung disease with systemic sclerosis: 4-year follow-up

By Tochimoto Akiko  

Modern Rheumatology, Vol. 21, Iss. 3, 2011-06 ,pp. : 296-301

Springer Publishing Company

Access to resources Recommend Favorite

Recurrent High-Dose Intravenous Methylprednisolone Succinate Pulse Therapy-Induced Hepatopathy in a Patient with Multiple Sclerosis

By  

Medical Principles and Practice, Vol. 20, Iss. 3, 2011-03 ,pp. : 291-293

Karger

Access to resources Recommend Favorite

Effect of High-Dose Intravenous Methyl-prednisolone Treatment on Intraocular Pressure in Multiple Sclerosis Patients with Relapse

By  

European Neurology, Vol. 68, Iss. 1, 2012-06 ,pp. : 20-22

Karger

Access to resources Recommend Favorite

Safety of Infliximab in Patients Suffering from Inflammatory Bowel Disease

By  

Digestion, Vol. 70, Iss. 1, 2004-09 ,pp. : 1-2

Karger

Access to resources Recommend Favorite

Low‐dose intravenous cyclophosphamide in systemic sclerosis: an open prospective efficacy study in patients with early diffuse disease

By Valentini G.   Paone C.   La Montagna G.   Chiarolanza I.   Menegozzo M.   Colutta E.   Ruocco L.  

Scandinavian Journal of Rheumatology, Vol. 35, Iss. 1, 2006-02 ,pp. : 35-38

Informa Healthcare

Access to resources Recommend Favorite